Portfolio company
Complement Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
Digital Health
About
This biotechnology company develops gene therapies and a precision medicine platform to treat complement-mediated diseases, such as geographic atrophy, for patients with vision loss.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.